Medicare Enrolled

Dr. Robert Mannel, M.D.

Neurology · Jacksonville Beach, FL
Practice pattern: Mixed Practice— Diverse clinical practice across multiple procedure types
Speaking/Promotional
1680 THE GREENS WAY STE 200, Jacksonville Beach, FL 32250
9048007380
In practice since 2012 (13 years)
NPI: 1093073181 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Mannel from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Mannel? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Mannel

Dr. Robert Mannel is a neurology in Jacksonville Beach, FL, with 13 years in practice. Based on federal Medicare data, Dr. Mannel performed 50,685 Medicare services across 1,275 unique beneficiaries.

Between the years covered by Open Payments, Dr. Mannel received a total of $52,626 from 48 pharmaceutical and/or device companies across 502 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in neurology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Mannel is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 13 years in practice▲ Top 1% volume in FL$ $52,626 industry payments

Medicare Practice Summary

Medicare Utilization ↗
50,685
Medicare services
Top 1% in FL for neurology
1,275
Unique beneficiaries
$7
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~3,899 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Injection, lecanemab-irmb, 1 mg33,193$1$3
Inclisiran injection (Leqvio) for cholesterol15,336$9$27
Denosumab injection (Prolia/Xgeva)720$19$52
Office visit, established patient (20-29 min)217$66$279
Evaluation of neuropsychological test, first hour197$100$312
Administration of psychological or neuropsychological test by technician, first 30 minutes196$25$80
New patient office visit, complex (60-74 min)196$166$656
Measurement of brain wave activity (eeg), awake and drowsy133$283$864
Assessment of and care planning for patient with impaired thought processing, typically 60 minutes108$206$654
Office visit, established patient (30-39 min)105$97$375
Administration of chemotherapy into vein, 1 hour or less103$100$369
New patient office visit (45-59 min)76$118$487
Drug injection, under skin or into muscle53$11$41
Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less52$49$181
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
0.1% high complexity
97.7% medium
2.2% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$52,626
Total received (2018-2024)
Avg $7,518/year across 7 years
Top 8% in FL for neurology
48
Companies
502
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$39,412 (74.9%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$11,190 (21.3%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$2,024 (3.8%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$44,414
2023
$3,885
2022
$1,880
2021
$188
2020
$161
2019
$311
2018
$1,787

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Otsuka America Pharmaceutical, Inc.
$39,769
ABBVIE INC.
$1,635
OnMark, Inc.
$1,400
Lundbeck LLC
$787
Lilly USA, LLC
$646
Promius Pharma LLC
$624
Biogen, Inc.
$611
Eisai Inc.
$566
SK Life Science, Inc.
$556
Novartis Pharmaceuticals Corporation
$545
Amgen Inc.
$520
Corium, LLC
$401
Sunovion Pharmaceuticals Inc.
$342
ARGENX US, INC.
$319
EMD Serono, Inc.
$290
ACADIA Pharmaceuticals Inc
$244
Janssen Pharmaceuticals, Inc
$230
Biohaven Pharmaceutical Holding Company Ltd.
$220
PFIZER INC.
$206
Neurelis, Inc.
$202
IMPEL PHARMACEUTICALS INC.
$197
IDORSIA PHARMACEUTICALS US INC
$164
GENZYME CORPORATION
$160
Genentech USA, Inc.
$158
Avanir Pharmaceuticals, Inc.
$148
Teva Pharmaceuticals USA, Inc.
$144
Alexion Pharmaceuticals, Inc.
$133
Grifols USA, LLC
$124
PORTOLA PHARMACEUTICALS, INC.
$120
Allergan Inc.
$117
UCB, Inc.
$117
JAZZ PHARMACEUTICALS INC.
$115
E.R. Squibb & Sons, L.L.C.
$112
Merz North America, Inc.
$110
Horizon Therapeutics plc
$82
CSL Behring
$82
Celgene Corporation
$63
Inspire Medical Systems, Inc.
$63
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)
$47
Octapharma USA, Inc.
$47
BANNER LIFE SCIENCES, LLC
$39
Novo Nordisk Inc
$30
TerSera Therapeutics LLC
$28
Catalyst Pharmaceuticals, Inc.
$27
GRT US Holding, Inc.
$25
Averitas Pharma Inc.
$24
GE HealthCare
$20
Acorda Therapeutics, Inc
$17
Top 3 companies account for 81.3% of total payments
Associated products mentioned in payments ›
ADUHELM · AJOVY · AMYVID · ANDEXXA · APTIOM · AUBAGIO · Adlarity · Aimovig · Austedo XR · BAFIERTAM · BOTOX · Briviact · CAPLYTA · ELIQUIS · EMGALITY · EPIDIOLEX · FIRDAPSE · Fycompa · Gamunex-C · Hizentra · INBRIJA · INSPIRE · KESIMPTA · KISUNLA · KRYSTEXXA · LEQEMBI · LEQVIO · Leqembi · MAVENCLAD · MAYZENT · NUEDEXTA · NUPLAZID · NURTEC ODT · Nuedexta · OCREVUS · Ocrevus · PANZYGA · PAXLOVID · Ponvory · QULIPTA · QUTENZA · QUVIVIQ · Qutenza · Quzyttir · REXULTI · Rystiggo · SKYCLARYS · SOLIRIS · Soliris · TYSABRI · Trudhesa · UBRELVY · UPLIZNA · VALTOCO · VYEPTI · VYVGART · VYVGART HYTRULO · XCOPRI · XEOMIN · ZEPOSIA · Zembrace
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (75%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in neurology and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 8% for neurology in FL.

Equivalent to $104 per 100 Medicare services performed
Looking for a neurology in Jacksonville Beach?
Compare neurologys in the Jacksonville Beach area by procedure volume, costs, and industry payment transparency.
Browse neurologys nearby

Geographic Context

Neurologys within 10 mi
154
Per 100K population
15.3
County median income
$68,447
Nearest hospital
BAPTIST MEDICAL CENTER BEACHES
0.0 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Mannel is a mixed practice specialist, with above-average Medicare volume (top 1% in FL), and high industry engagement (speaking/promotional, top 8%).

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Mannel experienced with injection, lecanemab-irmb, 1 mg?
Based on Medicare claims data, Dr. Mannel performed 33,193 injection, lecanemab-irmb, 1 mg services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Mannel receive payments from pharmaceutical companies?
Yes. Dr. Mannel received a total of $52,626 from 48 companies across 502 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Mannel's costs compare to other neurologys in Jacksonville Beach?
Dr. Mannel's average Medicare payment per service is $7. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Mannel) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →